Does Hysterectomy Raise Long-Term Urinary Incontinence Risk?

The awkward answer to “does hysterectomy raise long-term urinary incontinence risk?” is that several apparently conflicting headlines can be quoting real studies. A 2026 meta-analysis found a pooled odds ratio of 1.31 for urinary incontinence after hysterectomy, with a 95% confidence interval from 1.03 to 1.66. That interval barely clears 1.0, so the pooled estimate is statistically significant. The same paper also reported very high heterogeneity, I2=88.5%, and graded the certainty of evidence as “very low.” [1]

That is the passage-reading problem. The estimate is not fake. The significance is not irrelevant. The certainty grade is not decorative. If you are using this topic for MCAT-style research reasoning, the job is not to pick the scariest number or the most reassuring headline. The job is to ask what each number measured, over what follow-up, in which population, with which confounders handled.

A plain-language answer comes first: long-term registry studies often show that people with hysterectomy histories have higher later rates of stress urinary incontinence surgery, but symptom-based and more heavily adjusted cohort analyses can look weaker, null, or even protective. That does not make the literature useless. It means “hysterectomy urinary incontinence long term risk” is not one outcome. It is a bundle of choices about endpoint, metric, adjustment, follow-up, and certainty.

This is a study-method article for pre-med and MCAT readers, not medical advice. Anyone making a personal decision about hysterectomy, pelvic organ prolapse, urinary symptoms, or stress urinary incontinence surgery needs a clinician who can evaluate the actual indication, anatomy, surgical route, baseline symptoms, and alternatives.

Start with the number that looks decisive, then read the warning labels

An odds ratio compares the odds of an outcome in one group with the odds in another. In the 2026 meta-analysis, OR 1.31 means the pooled odds of urinary incontinence were higher in the hysterectomy group than in the comparison group. The 95% CI of 1.03–1.66 means the interval did not cross 1.0, the usual “no difference” value for an odds ratio. On that narrow question — did the pooled estimate reach statistical significance? — the answer is yes. [1]

But the same result also carries I2=88.5%. I2 is a heterogeneity statistic: it asks how much of the variation across study results is more than you would expect from sampling error alone. A high I2 does not automatically invalidate a meta-analysis, but it does change the tone of the conclusion. The pooled estimate is now less like one clean answer and more like an average drawn from studies that may not be measuring quite the same thing.

Then comes GRADE. The 2026 paper graded the certainty of evidence as “very low,” even while reporting a statistically significant pooled odds ratio. [1] That combination is not a contradiction. Statistical significance asks whether a result is compatible with a null effect under a particular model. Certainty grading asks whether the body of evidence deserves confidence after considering problems such as inconsistency, study limitations, indirectness, imprecision, and publication bias. A result can pass the first test and still perform poorly on the second.

This is exactly the sort of trap an MCAT passage can set without ever mentioning hysterectomy. The test does not need you to memorize gynecologic epidemiology. It needs you to avoid treating “p < 0.05” as if it erases heterogeneity, endpoint differences, or confounding.

The confounder that changes the story: preceding pelvic organ prolapse

The cleanest reasoning hinge comes from the 2024 Northern Finland Birth Cohort analysis by Salo and colleagues. In that cohort, de novo urinary incontinence did not differ significantly between the hysterectomy and reference groups: 5.6% versus 4.7%, p=0.416. The unadjusted odds ratio was 1.20, with a 95% CI of 0.77–1.86. After adjustment for preceding pelvic organ prolapse, the odds ratio became 0.54, with a 95% CI of 0.32–0.90. [2]

That is not a cute reversal. It is a warning about what the comparison groups contained before surgery entered the analysis. Pelvic organ prolapse can be related both to the likelihood of receiving hysterectomy and to later urinary symptoms. If people with preceding prolapse are overrepresented in the hysterectomy group, an unadjusted comparison can partially measure the burden of prolapse rather than the independent effect of hysterectomy.

Adjustment does not magically make an observational study causal. It depends on whether the important confounders were measured well and included appropriately. Still, the Salo result shows why the phrase “hysterectomy increased risk” is too fast if the model did not account for a pelvic-floor condition that helped sort people into the surgery group in the first place.

For an exam passage, this is where you slow down. “Adjusted” is not a synonym for “true,” and “unadjusted” is not a synonym for “false.” The point is narrower and more useful: if a covariate can plausibly influence both exposure and outcome, the adjusted and unadjusted estimates may answer different questions.

Registry hazard ratios are strong evidence for a narrower endpoint

Now compare that with the Nordic registry studies that often drive the “higher long-term risk” side of the conversation. Altman and colleagues used a Swedish nationwide registry and reported a hazard ratio of 2.4 for later stress urinary incontinence surgery among 165,260 exposed individuals compared with 479,506 controls. The association was highest within 5 years after hysterectomy, HR 2.7, and remained elevated at 10 or more years, HR 2.1. [3]

A hazard ratio is not the same as an odds ratio. It compares the rate at which an event occurs over time between groups. The “event” in the Altman study was not “reported leakage on a questionnaire.” It was stress urinary incontinence surgery. That is clinically meaningful, and registries can capture large numbers over long periods, but it is still a surgery-based endpoint. It depends on symptoms, care-seeking, referral, surgical eligibility, patient preference, and health-system practice.

A Danish registry study published in AJOG in 2023 points in the same direction for that endpoint. Christoffersen and colleagues reported an adjusted hazard ratio of 2.6, with a 95% CI of 2.4–2.8, for stress urinary incontinence surgery after hysterectomy. When vaginal hysterectomies were excluded, the estimate fell only to 2.4. [4]

Those are not weak-looking numbers. But they do not settle every version of the question. They support a narrower statement: in these Nordic registry settings, hysterectomy was associated with higher long-term rates of later stress urinary incontinence surgery. That is different from saying every symptom-based study must show the same magnitude, or that the estimate applies unchanged to every indication, surgical route, population, or health system.

Endpoint choice can make two valid studies appear to disagree

The endpoint distinction becomes visible in absolute numbers in the FINHYST 10-year follow-up. Tulokas and colleagues reported 2.2% stress urinary incontinence surgery and 4.8% urinary incontinence hospital visits over a median follow-up of 10.6 years. [5] Both are connected to urinary incontinence, but they are not interchangeable.

A questionnaire endpoint asks whether a person reports symptoms. A hospital-visit endpoint captures contact with a health-care system. A surgery endpoint captures a later procedure. Each endpoint filters the underlying symptom experience differently. Someone can have symptoms without surgery. Someone can have a registry event only after a chain of access, evaluation, diagnosis, and treatment decisions. A study of surgery can therefore show a strong association while a symptom study shows a weaker one, and both may be measuring their chosen endpoints correctly.

This is why “long-term urinary incontinence risk” needs tightening before comparison. Long-term risk of what — any leakage, stress urinary incontinence symptoms, mixed incontinence, overactive bladder symptoms, hospital visits, or surgery? If two abstracts use different endpoints, their effect sizes should not be lined up as if they were alternative answers to the same math problem.

The “60% higher risk” line needs its age boundary

Older systematic-review language still circulates in simplified form. Brown and colleagues reported an odds ratio of 1.6 in a 2000 systematic review, but that figure applied to women assessed at age 60 or older. [6] Detached from that boundary, “60% higher risk” becomes a more general claim than the source supports.

For MCAT-style reading, the move is simple: never carry an effect size away from its population label. Age at assessment matters. So do indication for hysterectomy, baseline pelvic-floor status, route of surgery, geography, and duration of follow-up. A number without its denominator and population is not evidence; it is a citation-shaped rumor.

Longer follow-up often makes the risk signal look stronger, but still not uniform

A 2025 AJOG meta-analysis brought in 60 studies and 3,567,848 participants. It reported within-10-year effect sizes of 1.29 for nonspecific urinary incontinence, 1.31 for stress urinary incontinence, 1.41 for overactive bladder, and 1.62 for mixed urinary incontinence. For stress urinary incontinence beyond 10 years, the reported effect size was 2.40. [7]

Those values are useful because they separate subtypes and follow-up windows. They also reinforce the need to stop treating “urinary incontinence” as a single box. Stress urinary incontinence, overactive bladder, and mixed urinary incontinence are not just different labels for the same endpoint. If a review reports different effect sizes for those categories, a reader should not collapse them back into one informal risk sentence.

The other side of the literature also has to be read with its time window attached. A 2026 BJOG symptom-focused meta-analysis reported an SUI odds ratio of 0.54, but the available follow-up was mostly short to medium term, roughly 6 weeks to 3 years. [8] That is not the same evidentiary object as a registry study following later incontinence surgery for a decade or more.

A disciplined answer to the risk question

So, does hysterectomy raise long-term urinary incontinence risk? The most defensible answer is conditional. Long-term Nordic registry studies show elevated associations with later stress urinary incontinence surgery, with hazard ratios around 2.4 to 2.6 in the Swedish and Danish data. [3][4] Meta-analytic results can also show increased pooled odds, including the 2026 OR 1.31, but that particular pooled estimate comes with very high heterogeneity and very-low-certainty evidence. [1]

At the same time, symptom-based and adjusted cohort data can look much less alarming. In the Northern Finland cohort, the crude de novo urinary incontinence comparison was not significant, and adjustment for preceding pelvic organ prolapse moved the odds ratio below 1.0. [2] That does not prove hysterectomy prevents urinary incontinence. It shows that baseline pelvic-floor disease can distort an unadjusted exposure-outcome comparison enough to change the apparent direction.

If you are reading for personal health information, the practical takeaway is to avoid self-diagnosing from a single risk percentage. If you are reading for MCAT practice, the takeaway is sharper: before comparing two effect sizes, freeze the variables. Metric first. Endpoint second. Population and geography third. Follow-up fourth. Adjustment set fifth. Certainty grade last, but never optional.

How to turn this into MCAT passage practice

A good passage question would not ask, “Is OR 1.31 bigger than 1?” That is too easy. It would ask why a statistically significant result might still receive a very-low-certainty grade, why a registry hazard ratio cannot be directly compared with a questionnaire odds ratio, or why adjustment for preceding pelvic organ prolapse changes interpretation. Those are reasoning questions, not vocabulary checks.

• When you see an odds ratio, ask whether the outcome is common enough that odds and risk may diverge in interpretation.
• When you see a hazard ratio, ask what event starts the clock, what event stops it, and whether the endpoint is a symptom, visit, diagnosis, or procedure.
• When a confidence interval crosses 1.0, do not call the result significant for OR or HR unless the passage gives another testing framework.
• When heterogeneity is high, ask whether the studies differ by endpoint, population, surgical indication, follow-up, or measurement method.
• When adjusted and unadjusted estimates differ sharply, identify the confounder rather than treating the two estimates as random disagreement.

This worked example belongs with the broader MCAT hub because the skill transfers: dense medical literature becomes manageable when you map exposure, outcome, metric, and design before reacting to the headline. For another study-mapping example, see How to Map the Chilean Mummy Smallpox DNA Study for MCAT. If you are building a full prep plan around this kind of passage reasoning, pair it with the MCAT study tools comparison and the 12-week MCAT study plan.

References

1. Hysterectomy and risk of urinary incontinence: a systematic review and meta-analysis — Frontiers in Urology, 2026.
2. Long-term effects of hysterectomy on urinary incontinence and pelvic organ prolapse: a Northern Finland Birth Cohort study — Acta Obstetricia et Gynecologica Scandinavica, 2024.
3. Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study — PubMed, 2007.
4. Hysterectomy and risk of stress urinary incontinence surgery: a Danish nationwide cohort study — American Journal of Obstetrics and Gynecology, 2023.
5. Urinary incontinence and pelvic organ prolapse after hysterectomy: a 10-year follow-up study — PMC, 2022.
6. Hysterectomy and urinary incontinence: a systematic review — The Lancet, 2000.
7. Association of hysterectomy with urinary incontinence: a systematic review and meta-analysis — American Journal of Obstetrics and Gynecology, 2025.
8. Urinary incontinence after hysterectomy: systematic review and meta-analysis — BJOG, 2026.